Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Brain Behav Immun. 2012 Nov 29;31:143–152. doi: 10.1016/j.bbi.2012.11.011

Table 1.

Characteristics of the control and MDD groups.

Controls n MDD n t, F, Chi p
Age (yr) 36.42 ± 12.13 19 37.00 ± 10.77 20 −1.58 0.88
Sex (% male) 37.00% 19 35.00% 20 0.12 0.91
BMI 24.48 ± 3.73 19 24.78 ± 4.29 20 −0.23 0.82
Ethnicity 19 20 0.84 0.84
 Caucasian 73.68% 70.00%
 African-American 15.79% 10.00%
 Asian 5.26% 10.00%
 Other or mixed 5.26% 10.00%
Current tobacco use (%) 19 20 2.30 0.32
 None 89.47% 75.00%
 Some days 10.53% 15.00%
 Daily 0.00% 10.00%
Lifetime tobacco use (%) 42.11% 19 50.00% 20 0.48 0.63
IDS 4.95 ± 4.89 19 37.21 ± 9.59 14 −11.53 0.00
F2-IsoP (ng/ml) 0.044 ± 0.015 19 0.043 ± 0.016 19 0.11 0.75
IL-6 (pg/ml) 0.73 ± 0.37 18 0.84 ± 0.823 20 0.75 0.39
IL-10 (pg/ml) 0.55 ± 0.61 18 0.40 ± 0.66 19 0.03 0.87
IL-6/IL-10 8.63 ± 12.21 18 11.68 ± 14.20 19 0.00 0.95

Data are means ± SD of raw data. p values for IL-6, IL-10, IL-6/IL-10, and F2-IsoP were derived from natural log-transformed data. Between-group means comparisons were assessed by univariate ANCOVA for F2-isoP’s and IL-6, adjusted for BMI, and IL-10 and IL-6/IL-10, adjusted for current tobacco use. The sample sizes above were not identical across all variables where data were missing.